Navigation Links
Schering-Plough Wins Three of Scrip's Top Pharma Industry Awards
Date:12/5/2007

KENILWORTH, N.J., Dec. 5 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) was honored by Scrip World Pharmaceutical News last night with three top pharmaceutical industry awards: Large Pharma Company of the Year, Management Team of the Year, and Executive of the Year for Fred Hassan, Schering-Plough chairman and CEO.

The Scrip Awards are designed to recognize excellence and achievement within the pharmaceutical and biotech industries. Scrip World Pharmaceutical News, a leading provider of news and analysis for the global pharmaceutical and biotechnology industries, held its third annual awards ceremony last night in London.

"We are honored and inspired by winning these three awards," said Hassan. "They are a testament to the courage and tenacity of our people around the world who have executed the remarkable transformation of Schering-Plough on our special long-term journey.

"The passion of our people for our science, for our customers and for our patients is a special strength. As we now launch our combination with Organon BioSciences, our people are uniting around that passion. We will be working hard to realize the exciting new promise of our company," Hassan said. "And we will not lose our sense of humility!"

Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription and consumer products as well as to animal health products. In November 2007, Schering-Plough acquired Organon BioSciences, with its Organon human health and Intervet animal health businesses, marking a pivotal step in the company's ongoing transformation. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its approximately 50,000 people around the world. The company is based in Kenilworth, N.J., and its Web site is http://www.schering-plough.com.


'/>"/>
SOURCE Schering-Plough Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
2. Schering-Plough Announces Pricing of Senior Notes Offering
3. Schering-Plough to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
4. Schering-Plough Receives Approval from European Commission for Planned Acquisition of Organon BioSciences N.V.
5. Schering-Plough Completes Acquisition of Organon BioSciences
6. KGI Elects Three New Members to Board of Trustees
7. Stimuvax(R) Phase II data highlight three-year survival results for patients with non-small cell lung cancer
8. Three Studies by Independent Scientists Highlighting Pressure Cycling Technology (PCT) to be Presented this Week at the British Mass Spectrometry Societys 29th Annual Meeting
9. Weil Gotshal Wins Major Victory for Applera; Secures Summary Judgment Invalidating Three Patents
10. European Union has Three-Speed Healthcare System - Many Countries Lagging in Reform
11. Three PDX (Pralatrexate) Studies Presented at the 2007 AACR-NCI-EORTC Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... ... May 02, 2016 , ... F.E.E.D. Co., the Feline ... their revolutionary, veterinarian-designed product for indoor cats. The NoBowl Feeding System replaces the ... food the way nature intended. NoBowls make cats happy and healthy. , Since ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... is excited to announce the launch of the Proove Health Foundation . ... and education to promote the use of personalized medicine for tackling the nation’s ...
(Date:4/29/2016)... , April 29, 2016 ... Transparency Market Research "Separation Systems for Commercial Biotechnology ... Trends, and Forecast 2015 - 2023", the separation ... US$ 10,665.5 Mn in 2014 and is projected ... 2015 to 2023 to reach US$ 19,227.8 Mn ...
(Date:4/29/2016)... ... April 29, 2016 , ... Summit for Stem Cell has received a ... a patient-specific stem cell therapy for the treatment of Parkinson’s disease. The Summit research ... at The Scripps Research Institute in San Diego, CA. , The aim ...
Breaking Biology Technology:
(Date:5/3/2016)... 3, 2016  Neurotechnology, a provider of high-precision ... Automated Biometric Identification System (ABIS) , a complete ... MegaMatcher ABIS can process multiple complex biometric transactions ... of fingerprint, face or iris biometrics. It leverages ... and MegaMatcher Accelerator , which have been ...
(Date:4/28/2016)... and BANGALORE, India , April 28, 2016 ... a product subsidiary of Infosys (NYSE: INFY ), ... a global partnership that will provide end customers ... mobile banking and payment services.      (Logo: ... innovation area for financial services, but it also plays a ...
(Date:4/28/2016)... , April 28, 2016 First quarter 2016: ... up 966% compared with the first quarter of 2015 ... SEK 589.1 M (loss: 18.8) and the operating margin was 40% ... 0.32) Cash flow from operations was SEK 249.9 M ... revenue guidance is unchanged, SEK 7,000-8,500 M. The operating ...
Breaking Biology News(10 mins):